Sponsor
Verona Pharma PLC
3 More London Riverside, SE1 2AQ, United Kingdom
About the sponsor
Verona Pharma PLC’s clinical research is focused on non-cystic fibrosis bronchiectasis, with attention to chronic airway disease and the prevention of pulmonary exacerbations.
- Non-cystic fibrosis bronchiectasis
- Chronic airway inflammation
- Pulmonary exacerbations
The sponsor’s current trial activity is centered on inhaled respiratory therapy for patients with persistent bronchiectatic lung disease.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.